PPARG and breast cancer: Zhou and coworkers found that troglitazone and rosiglitazone stimulate autophagy in triple-negative MDA-MB-231 breast cancer cells in a PPARγ-dependent manner through the upregulation of the hypoxia-inducible factor 1 (HIF1α), which is required for the hypoxia-induced autophagy [88].